IRCT20220211053992N4招募中未知
Bioequivalence study of Losartan 50mg capsule manufactured by Hakim Co. compared with innovator product
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
不适用
Investigating the in vivo bioequivalence of losartan 50 mgIRCT20210519051345N23Tabriz University of Medical Sciences24
已完成
不适用
A bioequivalence study of losartan H 50/12.5 mg tablet compared to Hyzaar 50/12.5 mg tablet manufactured by Merck in 24 healthy volunteers under fasting conditioBlood concentration of test and reference drug is compared.IRCT20220209053979N2Alborz Darou24
招募中
不适用
Bioequivalence Evaluation of Losartan and Cozaar® formulations in healthy volunteersIRCT20130603013572N5Daana pharma.Co26
尚未招募
Unknown
Bioequivalence study of Losar H® 50/12.5 mg in 24 healthy male under fasting conditionsIRCT20180620040164N47Razak Pharmaceutical Co.24
已完成
不适用
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted ConditionsHypertensionNCT01216852Roxane Laboratories40